Announcements

Michael R. Manley, SVP and General Counsel of 1-800-Flowers.com, Inc., filed a statement of changes in beneficial ownership on November 9, 2026, reporting a tax-withholding disposition of Class A Common Stock that occurred on November 5, 2026.

ChoiceOne Financial Services, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 9, 2026, reporting third-quarter net income of $14,545 thousand and total assets of $4.46 billion.

JPMorgan Chase Financial Company LLC filed a Free Writing Prospectus on November 6, 2026, disclosing summary terms for 3-Year Worst-of RTY/SPX/SX5E Contingent Income Auto-Callable Securities with an expected pricing date of November 9, 2026.

Paul Bracher, President of CFR and an officer of Cullen/Frost Bankers, Inc., filed a Form 4 on November 9, 2026, disclosing the sale of 2,900 shares of common stock on November 5, 2026.

Nelson Niviades Tejada Jr., Chief Merchandising Officer of 1-800-Flowers.com, Inc. (NASDAQ:FLWS), filed a statement of changes in beneficial ownership on November 9, 2026, disclosing a share withholding transaction dated November 5, 2026.

David Elliot Lazar filed a Schedule 13D with the SEC on November 9, 2026, disclosing the acquisition of preferred shares in Highway Holdings Ltd (NASDAQ:HIHO) totaling $7,000,000 in aggregate purchase price, following a triggering event dated November 4, 2026.

Eli Lilly and Company (NYSE:LLY) announced on November 9, 2026, positive Phase 3 results from the ATTAIN-OSA clinical program evaluating Foundayo (orforglipron) in adults with moderate-to-severe obstructive sleep apnea and obesity or overweight, with results presented at the American Heart Association Scientific Sessions 2026 …